Issue#: 524/2019

Spot values at a glance:

USD/SGD

USD/CNH

AUD/USD

USD/JPY

USD/CAD

GBP/USD

Daily Observations:

Asian stocks were little changed in earlier trading Wednesday as traders await the next page in the US-China trade war and any fresh narratives on the Fed, which releases minutes from its last policy meeting today. Earlier, US stocks closed higher after the US decided to grant limited relief for consumers and carriers that do business with Huawei Technologies Co. Safe havens such as Treasuries and the yen were flat.

 

Trump Provides Limited Huawei Relief:

The Commerce Department on Monday granted a 90-day relief for certain US broadband companies and wireless customers using Huawei Technologies Co. equipment. The temporary license covers continued operation of existing networks and equipment as well as support to existing handsets and other limited actions, according to a notice published in the Federal Register Monday.

 “This license will allow operations to continue for existing Huawei mobile phone users and rural broadband networks,” Commerce Secretary Wilbur Ross said in an emailed statement on Monday.

The Trump Administration blacklisted Huawei on Friday, jeopardizing its supply of American components from semiconductors to the Google apps that run on its smartphones. For Huawei phone users, the temporary reprieve means Google will be able to provide key Android security updates during the 90-day time frame, but future Huawei phones will still lack Google’s apps.

Ross said last week on Bloomberg Television that the administration had a plan in place to deal with rural providers that use the Chinese company’s equipment in existing 4G networks.

The move comes after the Trump administration placed the Chinese telecoms giant on an export blacklist that requires American companies to apply for a special license to sell products to the world’s largest networking gear maker. The impact of the Trump administration’s threats to choke Huawei reverberated across the global supply chain on Monday, hitting some of the biggest component-makers.

 

China Surveillance Giant Tanks on US Ban Report:

Hangzhou Hikvision Digital Technology Co. plunged as much as the daily  limit after New York said the Trump administration was considering curtailing the flow of American technology to China’s top maker of video surveillance gear.

The stock fell as much as 9.6% lower as of 9:50a.m. in Shenzhen. The White House will make a final decision in coming weeks on whether to limit exports of US components to Hikvision, as it’s done with Huawei Technologies Co., the Times reported, citing unidentified people familiar with the matter.

Hikvision has grown into a surveillance giant, selling its cameras around the world after cashing in on China’s obsession with monitoring its citizens. Its devices use artificial intelligence, enabling them to conduct facial recognition on a vast scale. That’s helped it build a dominant position in a market that BIS Research says was worth $32billion in 2017 and will grow 16% a year by 2023. Hikvision doesn’t have a a global counterpart close to its scale and Zhejiang Dahua Technology Co., its closest rival, is about a sixth of its size.

 

Theresa May’s New Brexit Referendum Plan Unwelcomed:

Theresa May made a desperate final gamble to get her Brexit deal through the British Parliament before she’s thrown out of office, but her efforts looked doomed.

In a hastily arranged speech on Tuesday, the embattled prime minister promised to give members of Parliament a vote on whether to call another referendum to ratify Britain’s divorce from the European Union. It’s something many MPs, including scores in the opposition Labour Party, have been calling for, but she made it conditional on them backing her deal first.

Within minutes of her speech ending, the backlash began. Pro-Brexit Conservative MPs joined the opposition leader Jeremy Corbyn and May’s Northern Irish allies to condemn her proposals. They vowed to vote against them in the House of Commons next month.

The failure of May’s deal would throw the UK into renewed turmoil and uncertainty. The outcome of Brexit would be almost impossible to predict as it will be left to May’s successor as Tory leader and prime minister to complete the process.

Leaving the EU with no deal, or even remaining inside the bloc could be back on the table once May is gone. Boris Johnson, who has said he’d be prepared to leave without an agreement, is the front-runner in the leadership race that’s unofficially under way. Johnson was quick to come out against May’s latest plan, as was pro-Brexit rival Dominic Raab.

 

Bullard Admits Hike Last December Was “Slightly Overdone”:

US policy makers may have “slightly overdone it” by raising interest rates in December, though it’s premature to talk about a rate cut, said Federal Reserve Bank of St. Louis President James Bullard.

“Rates are at a good place in the US right now, if anything we are a little restrictive I would say,” Bullard said in an interview with Bloomberg Television Wednesday in Hong Kong. “I am concerned we may have slightly overdone it with our December rate hike but I was pleased that the committee pivoted.”

Bullard, a voter this year on the FOMC, has been consistently among the more dovish members of the policy panel, arguing against raising rates in the absence of clear inflation pressures.

Describing low inflation expectations as a concern, Bullard said he argued against the December hike and pegged the neutral level at 2%, “so we are a little bit tight right now.” While a rate cut would send an important signal that the Fed is determined to hit its inflation target, such a move would be premature at this point, Bullard said. On the US trade war with China, Bullard said farmers are very concerned about rising tariffs, though he added it may take some months before the duties begin to impact Fed policy.

Investors are betting on a rate cut before the end of the year, according to prices in interest rate futures contracts.

 

China Dollar-Loan Market Slumps This Year:

Dollar loans to Chinese borrowers have cratered this year, thanks to both a decline in demand and increased wariness among lenders amid escalating US-China tensions.

Syndicated dollar loan issuance to Chinese borrowers has tumbled 62% from the start of the year through May 17, to $7.3 billion, according to data compiled by Bloomberg. That’s the lowest level since 2012.

Many instead are turning to domestic funding, taking advantage of policy makers’ moves to bolster credit growth as China’s economy slows. Yields on weaker companies’ bonds have fallen near the lowest in 30 months, luring issuers including developers back home for funding. Local corporate-bond issuance has jumped 33.5% so far, to a record high of 4.4 trillion yuan.

A weakening exchange rate has also enhanced the appeal of yuan borrowing, and raised the risk of servicing overseas debt. Dollar-bond issuance has also slowed this year, though not by as much as in the loan market. Chinese entities’ dollar-note sales are just 5.7% down on last year, according to data compiled by Bloomberg.

 

Most Unloved Sector is Most Favored by Hedge Funds:

According to a Bloomberg article, despite the increased political risk in the health-care industry of late, hedge funds have been increasing their exposures in this sector to the highest since 2010.

In a quarter when calls for drug pricing and “Medicare-for-All” grew louder, hedge funds raised their holdings in stocks from drugmakers to health insurers. At the end of March, their exposure increased to the highest since 2010, making the group the most crowded among 11 industries, regulatory filings compiled by RBC Capital Markets showed.

Though the worst industry in the S&P 500 this year, health-care has its devotees. The stocks are cheaper than the market, their revenues appear more resilient amid an economic slowdown or a trade war, and dealmaking is reviving. But the bets haven’t worked and the industry’s growing popularity leaves some skeptical.

Health care has trailed all other major industries in the S&P 500, rising 3% this year, compared with a 14% gain for the broad benchmark. Hedge funds are unbowed. At the worst point of the rout in April, they were aggressively buying the dip, data compiled by JPMorgan’s prime brokerage unit showed.

Investors may also be turning to the sector in the wake of escalating geopolitical tensions and a pick-up in volatility in broader markets. As a domestic industry, health care has been a haven for trade-weary investors. But prepare for more turbulence in coming months as political pressure is likely to resurface, sector analysts warned. For one, the Democratic presidential primary debates are set to start in June. A ruling from an appeals court on the future of Obamacare is also pending.

 

 

Sources: Bloomberg

FX Updates:

USD/SGD:

Spot: 1.3778

USDSGD continued today to fluctuate near a 5-month high, just shy of its 1.3800 handle. The pair has gained 1.3% so far this month, but looks set to pare some of the gains over the near term. A retracement back to 1.3700 is likely before the key resistance of 1.3873 is reached.

 

AUD/USD

Spot: 0.6882

AUDUSD remained on the back foot, near 0.6880 following poorer-than-expected Australian construction data earlier today, strengthening the case for a rate cut in June. RBA Governor Lowe had earlier said the central bank will consider cutting its cash rate next month  to bolster the labor market and help return inflation to target. More Aussie weakness is expected over the medium term; the next support at 0.6828 is not expected to hold over the next few weeks.

 

USD/CAD:

Spot: 1.3402

USDCAD slipped back to the 1.3400 handle, following a stronger Canadian dollar which was boosted after the US reached an agreement with Mexico and Canada to cancel steel and aluminium tariffs. The FX pair is expected to maintain within the 1.3400-1.3500 range over the near term.

 

USD/CNH:

Spot: 6.9322

For the third straight day, USDCNH pared its sharp rise in May, which saw the pair gain as much as 3.1% since end-April. The pair continues to hold above the 6.9000 handle. The 2018-high at 6.9805 remains the key resistance target. Up and down side risks continue to loom large, as traders await fresh narratives on the US-China trade dispute.

 

USD/JPY:

Spot: 110.63

As predicted last week, USDJPY has completed its rebound back up to the 110.80 region. Continued safe haven demand should drive the pair back below 110; a retest of 109 is possible.

 

GBP/USD:

Spot: 1.2715

GBPUSD remains supported at the 1.2700 level, despite renewed Brexit uncertainty. UK PM May’s recent proposal to offer parliament a vote on holding a second Brexit referendum was met with strong scepticism among key lawmakers. 1.2700 is not expected to hold for long; a break below is likely to lead to a retest of the 1.2441 low last reached earlier this year.

    

© Jachin Capital Pte Ltd

UEN: 201419754M


The contents of this document are for information only and is taken or compiled from sources that we, Jachin Capital Pte Ltd, believe to be reliable. To the maximum extent permitted by law, we do not make any representation or warranty (express or implied) that this information is accurate, timely or complete and it should not be relied upon as such. Opinions expressed are our current opinions as at the date of this document only and are subject to change without notice. We endeavour to update on a reasonable basis the information discussed but regulatory, compliance or other reasons may prevent us from doing so. The publication and distribution of this document is not and does not imply any form of endorsement of any person, entity, service or product described or appearing here. This is not and does not constitute or form an offer to buy or sell nor the solicitation of an offer to buy or sell any security or financial instrument nor to participate in any particular trading or investment strategy. We are not soliciting any action based on this document. The information, services and products described or appearing here are intended only for Accredited Investors (as currently defined in the Securities and Futures Act) and are not intended for nor targeted at the public in any specific jurisdiction. This information does not take into account the particular investment objectives, financial situations or needs of individual investors. Investors should seek independent financial, tax or legal advice or make independent investigations as considered necessary or appropriate before making an investment decision. Investments involve risk. Any past performance, projection, forecast or simulation of results is not necessarily indicative of the future or likely performance of any investment instrument.

Essential SSL

DISCLAIMER

DISCLAIMER

Accredited Investors

By using this web-site you represent and warrant that you are an Accredited Investor based on the definition provided in Section 4A(1a) of the Securities and Futures Act:

“Accredited investor” means:

  1. An individual –
  2. whose net personal assets exceed in value SGD2 million (or such other amount as the MAS may prescribe); or
  3. whose income in the preceding 12 months is not less than SGD300,000 (or such other amount as the MAS may prescribe)
  4. a corporation with net assets exceeding SGD10 million in value (or such other amount as MAS may prescribe).”

 

Users represent that they are Accredited Investors who are using this web-site for information purposes only.
The materials provided on this web-site are strictly for information only and is not an offer or a solicitation to deal in any of the financial instruments referred to herein or to enter into any legal relations, nor an advice or recommendation with respect to such financial instruments. Users should independently evaluate each financial instrument and consider the suitability of such financial instrument, taking into account their specific investment objectives, risk profile, financial situation or particular needs and consult independent advisers as necessary, before dealing in any financial instruments mentioned on this web-site. While reasonable efforts have been made to ensure that the contents have been obtained or derived from sources believed by Jachin Capital to be reliable, Jachin Capital does not make any express or implied representations or warranties as to the accuracy, timeliness or completeness of the information, data or prevailing state of affairs that are mentioned herein and do not accept any liability for any loss or damage whatsoever, direct or indirect, arising from or in connection with the use of or reliance on the contents of this web-site. Jachin Capital reserves the right to act upon or use the contents herein at any time, including before its publication on this web-site.

Past performance is not always indicative of likely or future performance. All investments involve an element of risk, including capital loss. Persons who are interested to invest in such financial instruments should read the risk disclosures and governing terms and conditions that are set out in the relevant offering documents.

We observe and obey the laws and regulations of the Personal Data Protection Act (PDPA) – click here to view the full notice.

 

ACKNOWLEDGEMENT AND CONSENT

  • [ ACCEPT ] I acknowledge that I have read and understood the Terms and Conditions and the Data Protection Notice. I consent to the collection, use and disclosure of my personal data by Jachin Capital for the purposes set out in the Notice.

 

  • [ DECLINE ] I do not would like to receive information about the goods and services which may be provided by Jachin Capital Pte Ltd , including (but not limited to) offers, promotions and information about new goods and services.